|

A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship

RECRUITINGN/ASponsored by Abramson Cancer Center at Penn Medicine
Actively Recruiting
PhaseN/A
SponsorAbramson Cancer Center at Penn Medicine
Started2026-01-20
Est. completion2028-12
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
Locations1 site

Summary

The MILES Study is a longitudinal, mixed-methods investigation of urinary biomarkers, energy balance, and lifestyle modifications in diverse women during early breast cancer treatment. The study's overarching goal is to assess dietary quality and physical activity changes over time using reliable, scalable tools suitable for clinical or population settings, supporting newly diagnosed patients in adopting and maintaining healthy behaviors through treatment and survivorship.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Adult women (age 18 years or older)
* Able to read English or Spanish
* Newly diagnosed with primary stage 0, I, II, or III breast cancer
* Pathological diagnosis within the previous 60 days
* Scheduled to have surgery with a Penn Medicine surgeon

Exclusion Criteria:

* Women age less than 18 years
* Women without a new primary breast cancer diagnosis
* Women who are pregnant

Conditions2

Breast CancerCancer

Locations1 site

Abamson Cancer Center of the University of Pennsylvania
John Plastaras, MD, PhD855-216-0098PennCancerTrials@emergingmed.com

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.